Trade Summary

5 days ago, Katkin Keith, serving as Dir at Emergent Biosolutions Inc. (EBS), sold 15,481 shares at $8.28 per share, for a total transaction value of $128,183.00. Following this transaction, Katkin Keith now holds 96,294 shares of EBS.

This sale represents a 14.00% decrease in Katkin Keith's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 30, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 4, 2026, 4 days after the trade was made.

Emergent Biosolutions Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.